MedTrace Logo

Routine Iron Prophylaxis During Pregnancy

NCT00488579 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 4326

Last updated 2017-11-30

No results posted yet for this study

Summary

Comparison of two policies of iron administration during pregnancy in regard to health and program feasibility in an area with endemic malaria and high prevalence of HIV infection. The policies are: 1) routine iron prophylaxis, 2) screening and therapy with iron.

Conditions

  • Pregnancy

Interventions

DRUG

Two policies of iron prophylaxis

60mg ferrous sulphate daily (+folic acid); Screening and therapy: Hb measurement on each visit, Hb\>9g/dl only folic acid, Hb\<9g/dl 60-120 of ferrous sulphate daily (+folic acid).

Sponsors & Collaborators

  • Academy of Finland

    collaborator OTHER

  • National Istitute For Health and Welfare, Finland

    lead OTHER_GOV

Principal Investigators

  • Elina Hemminki, PhD, MD · THL

  • Baltazar Chilundo · Eduardo Mondlane University

Study Design

Allocation
RANDOMIZED
Purpose
HEALTH_SERVICES_RESEARCH
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2007-05-31
Primary Completion
2007-12-31
Completion
2016-05-31

Countries

  • Mozambique

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00488579 on ClinicalTrials.gov